MTEX
MANNATECH INCCompany Information
- Company Name
- MANNATECH INC
- CIK
- CIK0001056358
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- MTEX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- MTEX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-20
- Last sale
- 2024-09-09
- Shares purchased (TTM)
- 14,903
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 147,131
- Shares outstanding
- 1,930,000
- Ownership
- 7.62%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 77.51%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 6 | 7 | 6 | 7 | 9 | 11 | 12 | 9 | 8 | 8 | 8 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Income Taxes Receivable | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 10 | 10 | 10 | 11 | 12 | 10 | 12 | 13 | 14 | 15 | 15 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | ||||||
| Capitalized Contract Cost Net Current | - | - | - | - | - | - | - | 2 | 2 | - | 2 | ||||||
| Deferred Sales Commission | - | - | - | - | 1 | - | 1 | - | 2 | - | 2 | ||||||
| Assets Current | 19 | 21 | 21 | 22 | 27 | 26 | 29 | 28 | 28 | 28 | 29 | ||||||
| Property Plant And Equipment Net | - | - | 2 | 3 | - | 3 | - | - | - | 4 | - | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 3 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 3 | 4 | 2 | 2 | 3 | 3 | - | 3 | - | ||||||
| Other Assets Noncurrent | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 7 | 4 | 7 | ||||||
| Construction In Progress Gross | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Deferred Income Tax Assets Net | 0 | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 27 | 30 | 30 | 34 | 37 | 36 | 41 | 40 | 41 | 41 | 42 | ||||||
| Deferred Tax Assets Liabilities Net | - | - | - | - | - | - | - | - | - | 2 | - | ||||||
| Capital Lease Obligations Current | - | - | - | - | - | 0 | - | - | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 3 | 3 | 3 | 3 | 4 | 4 | 5 | 6 | 6 | 5 | 8 | ||||||
| Deferred Revenue Current | - | - | - | - | - | 3 | - | - | - | 5 | - | ||||||
| Deferred Revenue | - | - | - | - | 2 | - | 3 | 4 | 4 | - | 4 | ||||||
| Contract With Customer Liability Current | 2 | 3 | 3 | 2 | - | 3 | - | - | 4 | - | 4 | ||||||
| Accounts Payable Current | 4 | 3 | 2 | 4 | 4 | 2 | 4 | 3 | 5 | 4 | 4 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 2 | 1 | 1 | 2 | - | - | 2 | - | ||||||
| Taxes Payable Current | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Liabilities Current | 17 | 19 | 19 | 20 | 23 | 21 | 23 | 24 | 26 | 26 | 26 | ||||||
| Capital Lease Obligations Noncurrent | - | - | - | - | - | - | - | - | 1 | 1 | 1 | ||||||
| Long Term Notes Payable | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | - | 0 | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | - | 3 | - | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 4 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | - | 1 | - | ||||||
| Deferred Income Tax Liabilities Net | 10 | 10 | 10 | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities | 32 | 35 | 35 | 27 | 29 | 27 | 31 | 32 | 31 | 31 | 32 | ||||||
| Commitments And Contingencies | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
Stockholders Equity | |||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | ||||||
| Retained Earnings Accumulated Deficit | -12 | -13 | -14 | -3 | -0 | 1 | -1 | -1 | -0 | -1 | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -7 | -6 | -5 | -4 | -5 | -6 | -2 | -4 | -2 | -1 | -3 | ||||||
| Treasury Stock Value | - | - | - | - | -20 | -20 | -20 | -20 | -20 | -21 | -21 | ||||||
| Treasury Stock Common Value | -19 | -19 | -20 | -20 | - | -20 | - | - | - | - | - | ||||||
| Stockholders Equity | -5 | -6 | -5 | 7 | 8 | 9 | 10 | 8 | 10 | 10 | 11 | ||||||
| Liabilities And Stockholders Equity | 27 | 30 | 30 | 34 | 37 | 36 | 41 | 40 | 41 | 41 | 42 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | ||||||
| Common Stock Shares Issued | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Shares Outstanding | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMANNATECH INC (MTEX) — SEC Financial Statements & Analysis
MANNATECH INC (MTEX) is a medicinal chemicals & botanical products company, incorporated in TX. MANNATECH INC trades on Nasdaq as: MTEX. MANNATECH INC (MTEX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, MANNATECH INC carries a market cap of $10.06M, a P/E ratio of -0.86x, a P/B ratio of -2.02x, a P/S ratio of 0.08x, an enterprise value of $7.57M, and an EV/EBITDA multiple of 2.67x. On profitability, it posts a gross margin of 75.59%, an operating margin of 0.92%, a net margin of -8.81%, a Return on Equity (ROE) of -896.21%, a Return on Assets (ROA) of -36.54%, and a Return on Invested Capital (ROIC) of 53.02%. Per share, it reports EPS of $-6.07, diluted EPS of $-6.07, free cash flow per share of $-2.14, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 15.65% year-over-year, net income growth of 5226.36% year-over-year, and EPS growth of 5146.33% year-over-year. On the balance sheet, it maintains a current ratio of 1.15x, a quick ratio of 0.46x, working capital of $2.55M, a debt-to-equity ratio of -6.53x, a debt ratio of 1.18, an interest coverage ratio of 2.21x, free cash flow of $-4.12M (TTM), and net debt of $-2.48M. Figures sourced from SEC EDGAR.
- Market Cap
- $10.06M
- P/E TTM
- -0.86x
- EPS TTM
- $-6.07
- P/B TTM
- -2.02x
- ROE TTM
- -896.21%
- ROA TTM
- -36.54%
- Debt To Equity
- -6.53x
- Free Cash Flow TTM
- $-4.12M
- Net Revenue TTM Growth 1Y
- 15.65%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MANNATECH INC in?
MANNATECH INC (MTEX) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does MTEX trade on?
MANNATECH INC (MTEX) trades on the Nasdaq.
Where is MANNATECH INC incorporated?
MANNATECH INC is incorporated in TX.
When was MANNATECH INC (MTEX)'s most recent SEC filing?
MANNATECH INC (MTEX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is MTEX's market cap?
MANNATECH INC (MTEX) has a market capitalization of $10.06M as of 2026-06-30.
What is MTEX's EPS (earnings per share)?
MANNATECH INC (MTEX)'s trailing twelve month EPS is $-6.07 as of 2026-06-30.
What is MTEX's ROE (return on equity)?
MANNATECH INC (MTEX)'s trailing twelve month Return on Equity (ROE) is -896.21% as of 2026-06-30.
What is MTEX's ROA (return on assets)?
MANNATECH INC (MTEX)'s trailing twelve month Return on Assets (ROA) is -36.54% as of 2026-06-30.
What is MTEX's ROIC (return on invested capital)?
MANNATECH INC (MTEX)'s trailing twelve month Return on Invested Capital (ROIC) is 53.02% as of 2025-09-30.
What is MTEX's EV/EBITDA?
MANNATECH INC (MTEX)'s trailing twelve month EV/EBITDA is 2.67x as of 2026-06-30.